Norfolk Hospital Joins Groundbreaking Generation Study Here at Maly IT, we’re really pleased to hear that our local Norfolk and Norwich University Hospital (NNUH) is taking part in the pioneering Generation Study. This national research project aims to transform how over 200 rare genetic conditions are diagnosed in newborns. The study will offer whole genome […]
Building upon Part 1’s exploration of product labelling as a defence against counterfeiting, this article (Part 2) delves into the intricate process of managing pharmaceutical labelling changes, crucial for compliance, minimising waste, and maintaining efficient supply chains across multiple markets. The seemingly simple act of changing a word or updating a logo on a pharmaceutical
The biopharmaceutical landscape is undergoing a significant transformation, driven by the increasing reliance on in silico simulations in drug discovery and therapeutics development. This computational approach offers a powerful tool for researchers. It allows for the prediction of drug-target interactions. Lead compounds can be optimised. The behaviour of molecules within biological systems can be simulated.
Credit: International Institute for Management Development (IMD) This February, I have decided to return to the topic of future readiness of pharmaceutical companies. It is a topic which has been gnawing away at me for well over a year, even before I first wrote about it (see Pulse 19 March 2024). Future readiness – a
Process compliance is crucial in new drug development and testing as it ensures that all regulatory requirements are met at each stage, from discovery to post-marketing surveillance. Compliance involves rigorous scientific research, data integrity, and adherence to Good Manufacturing Practices (GMP) and regulatory submissions such as the Clinical Trial Application (CTA) (Investigational New Drug –
Ever wondered what it’s like to run a genomics lab? There are a lot of complex procedures and processes to follow when carrying out hundreds of daily tests and experiments to ensure sampling is done correctly and that data gathered is accurate. The stakes are high for lab managers! Get it wrong even once and it
ProblemThe labelling and artworks department of this major multinational pharmaceutical company was having challenges in streamlining the process workflow. Projects were incorrectly prioritised, bottlenecks were created by other teams and operational output was below requirement. SolutionAs the system involved interaction with many regulators for multiple projects it was critical that our analysis and solution were
The Pharmaceutical industry is one of the most heavily regulated industries in the world. Every country has some number of rules or regulations with regards to drugs and pharmaceuticals and although they are often similar, they are not necessarily the same. This means that there are many laws and regulatory bodies that any global pharmaceutical
